Beau Webber

Chief Science Officer & Founder at Luminary Therapeutics

Dr. Webber’s laboratory is focused on synergizing genome engineering, stem cell biology, and adoptive cellular therapy to develop novel treatments for genetic disease and cancer. Research projects in the lab currently fall into two broad areas: the application of genome engineering to develop improved cell-based immune and gene therapies, and the development of “bottom-up” cancer models using human pluripotent stem cells.

Postdoctoral Fellowship in Pediatric Hematology, Oncology and Transplantation, University of Minnesota Medical School, Minneapolis, MN.


Timeline

  • Chief Science Officer & Founder

    Current role